A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.

TitleA new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.
Publication TypeJournal Article
Year of Publication2006
AuthorsColebunders, R, Moses, KR, Laurence, J, Shihab, HM, Semitala, F, Lutwama, F, Bakeera-Kitaka, S, Lynen, L, Spacek, L, Reynolds, SJ, Quinn, TC, Viner, B, Mayanja-Kizza, H
JournalThe Lancet infectious diseases
Volume6
Issue1
Pagination53-9
Date Published2006 Jan
ISSN1473-3099
KeywordsAnti-HIV Agents, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Developing Countries, Drug Monitoring, Drug Resistance, Viral, Hemoglobins, HIV, HIV Infections, Humans, Patient Compliance, Treatment Failure, Viral Load
Abstract

Monitoring the efficacy of antiretroviral treatment in developing countries is difficult because these countries have few laboratory facilities to test viral load and drug resistance. Those that exist are faced with a shortage of trained staff, unreliable electricity supply, and costly reagents. Not only that, but most HIV patients in resource-poor countries do not have access to such testing. We propose a new model for monitoring antiretroviral treatment in resource-limited settings that uses patients' clinical and treatment history, adherence to treatment, and laboratory indices such as haemoglobin level and total lymphocyte count to identify virological treatment failure, and offers patients future treatment options. We believe that this model can make an accurate diagnosis of treatment failure in most patients. However, operational research is needed to assess whether this strategy works in practice.

Alternate JournalLancet Infect Dis
Full Text
PubMed ID16377535
AttachmentSize
Robert+Colebunders-+idi-res1.pdf92.57 KB